John G. Cox
2012
In 2012, John G. Cox earned a total compensation of $4.1M as EVP, Pharmaceutical Operations Technology at Biogen, a 41% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $4,781 |
|---|---|
| Non-Equity Incentive Plan | $489,456 |
| Salary | $552,023 |
| Stock Awards | $2,884,380 |
| Other | $131,814 |
| Total | $4,062,454 |
Cox received $2.9M in stock awards, accounting for 71% of the total pay in 2012.
Cox also received $4.8K of change in pension value and nonqualified deferred compensation earnings, $489.5K in non-equity incentive plan, $552K in salary and $131.8K in other compensation.
Rankings
In 2012, John G. Cox's compensation ranked 1,610th out of 11,487 executives tracked by ExecPay. In other words, Cox earned more than 86.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,610 out of 11,487 | 86th |
Division Manufacturing | 576 out of 4,253 | 87th |
Major group Chemicals And Allied Products | 126 out of 1,198 | 90th |
Industry group Drugs | 67 out of 920 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 10 out of 160 | 94th |
Source: SEC filing on April 30, 2014.
Cox's colleagues
We found four more compensation records of executives who worked with John G. Cox at Biogen in 2012.